Chronology of Committee Work

Metabolife Records Show Company Knew of Adverse Health Effects

A report released by Sen. Durbin, Rep. Waxman, and Rep. Davis examines 13,000 adverse event reports received by Metabolife, the largest manufacturer of ephedra-containing dietary supplements. The records include nearly 2,000 reports of significant adverse reactions including deaths, heart attacks, and strokes

Enforcement of FDA Ad Regulations Drops Precipitously

In a letter to HHS Secretary Thompson, Rep. Waxman reveals that FDA enforcement actions against drug manufacturers for false or misleading claims in drug advertisements have dropped by 70% under the Bush Administration.

Social Security and Working Families in Los Angeles County

A report released by Rep. Waxman analyzes the impact of federal deficits on the Social Security contributions of working families in Los Angeles County.

Hearing on "The Holocaust Victims Insurance Relief Act of 2001"

The Subcommittee on Government Efficiency, Financial Management and Intergovernmental Relations held a hearing on H.R. 2693, the Holocaust Victims Insurance Relief Act of 2001.

Concerns About Ephedra-Containing Supplements

Rep. Waxman and other members have written Department of Health and Human Services Secretary Tommy Thompson to share their concerns about ephedara-containing dietary supplements.

Tobacco Companies Still Deny Harm of Cigarettes

As criticism of the tobacco industry has accelerated in recent years and calls for product regulation have grown, tobacco companies have defended themselves by saying they are now "responsible" corporations that aim to communicate honestly about their products. A new report released by Rep. Waxman examines recently submitted filings by the five largest cigarette manufacturers in the civil suit brought by the United States Department of Justice to evaluate the truthfulness of company statements.

Rep. Waxman Urges FTC to Reject Smokeless Claims

Rep. Waxman and Sen. Dick Durbin wrote the Federal Trade Commission to urge that the agency not permit smokeless tobacco to be marketed as a "safer" alternative to smoking. Citing new evidence that smokeless tobacco products are being marketed heavily in youth-oriented magazines, Rep. Waxman and Sen. Durbin also asked the National Association of Attorneys General to investigate the compliance of the United States Smokeless Tobacco Company with the multi-state Master Settlement Agreement which governs the way tobacco products are advertised and marketed in the U.S.

Luggage Screening Machines Not Used to Full Capacity

In a letter to Homeland Security Director Tom Ridge and Transportation Secretary Mineta, Rep. Waxman and Rep. Oberstar express concern that the Transportation Security Administration (TSA) has been, and continues to be, severely deficient in screening luggage for explosives at our nation’s airports. According to recent data, TSA is using less than 3% of existing explosive detection machines at maximum capacity levels.

Health Professional, Industry, and Advocacy Groups Oppose FDA Plan

On Aug. 26, Rep. Waxman wrote HHS Secretary Tommy Thompson to protest a dangerous FDA plan to make colored contact lenses available to children and others without medical supervision or manufacturing standards. Since then, Rep. Waxman's position that colored contact lenses are medical devices has received strong support from the major organizations representing eye health professionals, pediatricians, the major manufacturers of colored lenses now legally available in the United States, and Prevent Blindness, a national advocacy organization devoted to eye health and safety. Sen. Edward Kennedy has also written in opposition to the FDA plan.

Rep. Waxman asks EPA for Information Provided by Electric Utilities and Unions

Rep. Waxman asks EPA Administrator Christine Todd Whitman to release the information that convinced the EPA to reject a proposal that would have protected public health and the environment better than the President's Clear Skies Initiative.

Justice Department Responds to GAO Brief

The Justice Department files a brief with the court responding to GAO's latest brief regarding a motion to dismiss.

Letter to Army Secretary White on Enron Stock and Fake Trading Floors

Rep. Waxman and Senator Barbara Boxer ask Army Secretary Thomas White whether the Enron stock he divested more than 90 days after his appointment was held in an illiquid private equity fund, as he has previously stated, and if it was not, than to explain why he waited more than 90 days to divest these holdings. Rep. Waxman and Senator Boxer also ask Secretary White about news accounts that Enron Energy Services (EES) set up a fake trading floor to mislead visiting analysts while Secretary White was EES vice chairman.

Major Deficiencies in Homeland Security Bill

The Government Reform Committee minority staff released a summary of the major deficiencies in the legislation creating a new Department of Homeland Security, as well as other provisions affecting the jurisdiction of the Committee.

Energy Bill Rewards Industry Contributors

A new report by the Special Investigations Division for Rep. Waxman finds that energy interests that gave millions of dollars in campaign contributions will receive billions of dollars in tax breaks and subsidies.

Administration's Changes Undermine Medical Privacy Rule

Six members write Health and Human Services Secretary Tommy Thompson with questions on the Administration's proposed changes to the medical privacy rule, including the creation of a broad loophole through which drug companies could access patient health records without patient permission.

Questions on Proposed Medical Privacy Rule Changes

Six members wrote Health and Human Services Secretary Tommy Thompson with questions on the Administration's proposed changes to the medical privacy rule, including the creation of a broad loophole through which drug companies could access patient health records without patient permission.

Rep. Waxman Details EPA's "Sea Change"

At a Subcommittee hearing on elevating the Environmental Protection Agency to a cabinet-level Department, Rep. Waxman details EPA's retreat from its core missions over the past year-and-a-half.

Rep. Waxman Calls on Bush to Set an Example on Stock Earnings

In a letter to President Bush, Rep. Waxman calls on the President to consider donating to charity all or some of the profits from his sale of $848,560 worth of Harken Energy Company stock.

Government Reform Committee Markup of H.R. 5005

The Government Reform Committee held a meeting to consider H.R. 5005, the President's proposal for a new Department of Homeland Security. The Committee held a one-day markup in which approximately 50 amendments were offered and 35 were adopted. The reported bill is over 200 pages long, four times the length of H.R. 5005 as introduced.

CBO Estimate: Homeland Security Department Will Cost $3 Billion

In a letter to Majority Leader Armey and Democratic Whip Pelosi, Rep. Waxman released a Congressional Budget Office cost estimate that finds that the creation of a new Department of Homeland Security will cost about $3 billion over the next four years. The CBO estimate counters Administration claims that the creation of the new Department "would not 'grow' government."

Members Raise Questions on Homeland Security Department Proposal Details

Rep. Waxman and Rep. Obey, ranking member on the Appropriations Committee, wrote Director Of Homeland Security Ridge to address ten areas where questions have arisen over the details of the President's Department of Homeland Security proposal. These areas include the lack of a mechanism for coordinating a unified security strategy across the government and the many responsibilities given to the Department that have nothing to do with homeland security.

Senator Reid Urges Finding in Favor of GAO

Sen. Harry Reid files an amicus curiae (friend of the court) brief urging the court to decide the case in favor of GAO.

GAO Responds to Defendant's Motion to Dismiss

GAO files its reply to the Justice Department's motion to dismiss.

Prescription Drugs Are More Expensive in Rep. Waxman's Congressional District in California than in Canada, Europe, and Japan

Rep. Waxman released a report that shows dramatic price difference between what an average senior on the Westside of Los Angeles pays for prescription drugs compared to the price paid by seniors in other countries. Said Rep. Waxman, "A grandmother on the Westside has to pay more than twice as much for her drugs as a grandmother in France, in Canada, in Germany, in Italy, and in the United Kingdom. And for some drugs, seniors in Los Angeles are paying over three times more than seniors in other countries. This unconscionable gouging is unacceptable and has to end."

Prescription Drugs Are More Expensive in the 4th Congressional District in Arkansas than in Canada, Europe, and Japan

This report for Rep. Mike Ross of Arkansas is an example of the reports prepared by the Special Investigations Division that compare international drug prices to prices in the United States. It finds that seniors are forced to pay up to twice as much for drugs as consumers in Canada, Europe, and Japan.

Displaying Items 1226 to 1250 of 1458:

Previous Page • Next Page

[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]